Business
GlaxoSmithKline hoping to deliver Australia’s next COVID treatment – Sydney Morning Herald
The pharma giant has started the approvals process for a drug similar to what Donald Trump received.
GSK announced last year it plans to close its Melbourne manufacturing site in Boronia at the end of 2022 after 50 years. The companys research on the COVID treatment has all taken place overseas, with Australias low case numbers meaning it is difficult to run trials for treatments here.
Australia is currently focused on the rollout of coronavirus vaccines, but the local biotech sector has long said there needs to be more treatment options for patients who present with the virus – particularly as…
-
Noosa News24 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News24 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General22 hours agoSummah Richards, 12, mourned after fatal e-scooter in Laidley, Queensland
-
General20 hours agoAustralian Catholics mourning death of Pope Francis